Homologous recombination deficiency (HRD) and comprehensive genomic profiling (CGP)

How can in house CGP HRD (homologous recombination deficiency) benefit pancreatic cancer patients?Подробнее

Perché implementare un test CGP (Comprehensive Genomic Profiling) nel proprio laboratorio?Подробнее

What are the benefits of in house Comprehensive Genomic Profiling (CGP) vs send out?Подробнее

Benefits of Next Generation Sequencing (NGS) biomarker testing for cancer patientsПодробнее

Beneficios de la secuenciación masiva (NGS) para pacientes con cáncerПодробнее

Illumina Oncology - Homologous Recombination Deficiency (HRD) Testing in Ovarian CancerПодробнее

TruSight™ Oncology 500 HRD at IRCCS Pascale (Italy) ft. Prof. Nicola NormannoПодробнее

Introduction to Homologous Recombination Deficiency (HRD) assessmentПодробнее

TruSight™ Oncology 500 HRD at Oncopole Toulouse (France) ft. Dr. Guillaume BataillonПодробнее